美国使用 Repository Corticotropin 医保支出的趋势和特征
Trends and Characteristics of US Medicare Spending on Repository Corticotropin.
机构信息
College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland.
Department of Neurology, Oregon Health & Science University, Portland.
出版信息
JAMA Intern Med. 2017 Nov 1;177(11):1680-1682. doi: 10.1001/jamainternmed.2017.3631.
Abstract
This study uses Medicare Drug Spending Dashboard data to estimate the cost of repository corticotropin to the Medicare program and assess its within-specialty prescribing patterns.
摘要
本研究使用医疗保险药物支出仪表板数据来估算 repository corticotropin 对医疗保险计划的成本，并评估其在专科内的开方模式。
相似文献
1
Trends and Characteristics of US Medicare Spending on Repository Corticotropin.美国使用 Repository Corticotropin 医保支出的趋势和特征
JAMA Intern Med. 2017 Nov 1;177(11):1680-1682. doi: 10.1001/jamainternmed.2017.3631.
2
Area variation in Medicare physician spending.医疗保险医师支出的地区差异。
Health Aff (Millwood). 1992 Spring;11(1):224-34. doi: 10.1377/hlthaff.11.1.224.
3
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.向开具 Repository Corticotropin 处方的医师专家支付的行业款项。
JAMA Netw Open. 2018 Jun 1;1(2):e180482. doi: 10.1001/jamanetworkopen.2018.0482.
4
Geographic differences in Medicare spending.医疗保险支出的地区差异。
N Engl J Med. 2010 Oct 21;363(17):1677-8; author reply 1678-9. doi: 10.1056/NEJMc1008500.
5
Volume and intensity of Medicare physicians' services: an overview.医疗保险医生服务的数量和强度：概述
Health Care Financ Rev. 1990 Summer;11(4):133-46.
6
Are Drugs Substitutes or Complements for Intensive (and Expensive) Medical Treatment.药物是强化（且昂贵）医疗治疗的替代品还是补充品？
Am Econ Rev. 2011 May;101(3):393-397. doi: 10.1257/aer.101.3.393.
7
Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries.住院医师培训地区的支出模式以及随后执业医师为 Medicare 受益人为提供的护理支出。
JAMA. 2014 Dec 10;312(22):2385-93. doi: 10.1001/jama.2014.15973.
8
Variation in Physician Spending and Association With Patient Outcomes.医生支出的差异及其与患者预后的关联。
JAMA Intern Med. 2017 May 1;177(5):675-682. doi: 10.1001/jamainternmed.2017.0059.
9
Choosing wisely: changing clinicians, patients, or policies?明智选择：改变临床医生、患者还是政策？
JAMA. 2015 Feb 17;313(7):657-8. doi: 10.1001/jama.2014.17422.
10
Primary Care Physicians and Spending on Low-Value Care.初级保健医生与低价值医疗支出
Ann Intern Med. 2021 Jun;174(6):875-878. doi: 10.7326/M20-6257. Epub 2021 Jan 19.
引用本文的文献
1
Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.药品未按批准用途使用与药品未按批准用途营销：第2部分：药品未按批准用途营销对患者、临床医生和研究人员的影响
JACC Basic Transl Sci. 2023 Mar 27;8(3):359-370. doi: 10.1016/j.jacbts.2022.12.012. eCollection 2023 Mar.
2
Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.评估 2016 年至 2019 年期间日本泌尿科医生从制药公司获得的非研究款项。
Int Urogynecol J. 2023 Jun;34(6):1285-1292. doi: 10.1007/s00192-023-05463-y. Epub 2023 Feb 1.
3
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?行业向医生支付款项属于回扣。利益相关方应如何应对？
J Health Polit Policy Law. 2022 Dec 1;47(6):815-833. doi: 10.1215/03616878-10041205.
4
Hormonal Therapy for Infantile Spasms: A Systematic Review and Meta-Analysis.婴儿痉挛症的激素治疗：系统评价与荟萃分析
Front Neurol. 2022 Feb 10;13:772333. doi: 10.3389/fneur.2022.772333. eCollection 2022.
5
Changes in PBM Business Practices in 2019: True Innovation or More of the Same?2019年药品福利管理（PBM）业务实践的变化：是真正的创新还是一如既往？
J Manag Care Spec Pharm. 2020 Oct;26(10):1325-1333. doi: 10.18553/jmcp.2020.20213. Epub 2020 Sep 1.
6
Current understandings in treating children with steroid-resistant nephrotic syndrome.治疗类固醇抵抗型肾病综合征患儿的最新认识。
Pediatr Nephrol. 2021 Apr;36(4):747-761. doi: 10.1007/s00467-020-04476-9. Epub 2020 Feb 21.
7
Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.向开具 Repository Corticotropin 处方的医师专家支付的行业款项。
JAMA Netw Open. 2018 Jun 1;1(2):e180482. doi: 10.1001/jamanetworkopen.2018.0482.
本文引用的文献
1
Is There Any Reliable Clinical Evidence to Suggest That Acthar Is More Effective Than Other Forms of Corticosteroids in Treating Sarcoidosis and Other Diseases It Is Being Marketed to Treat?
Chest. 2016 Mar;149(3):886. doi: 10.1016/j.chest.2015.11.027. Epub 2016 Jan 14.
Zotero 插件